Given recent findings that stimulating the circadian clock slows tumor growth in a mouse model of melanoma (Kiessling et al., 2017), it is important to determine the extent of clock disruption across human cancers, in order to delineate the general potential of anti-tumor strategies based on restoring or improving clock function. This evidence concerns the gene CLOCK and cancer.